Does Heat Make Cancer Spread?

Everyday heat exposure, like a hot summer day or a sauna session, does not appear to make cancer spread. But the relationship between heat and cancer is far more layered than that simple reassurance suggests. In controlled medical settings, heat is deliberately used to fight tumors, and the evidence shows it can work. Yet when heat is applied incompletely during certain procedures, it can paradoxically accelerate tumor growth and even help cancer cells escape into the bloodstream. The answer depends almost entirely on the type of heat, the temperature range, how long it lasts, and whether it reaches the entire tumor.

What Happens to Cancer Cells Under Heat Stress

When cells experience a sudden rise in temperature, they activate a built-in emergency response. The body ramps up production of molecules called heat shock proteins, which act as cellular repair crews. Under normal circumstances, this is a survival mechanism that protects healthy tissue. But cancer cells hijack the same system. At least two of these proteins, Hsp27 and Hsp70, increase substantially as normal cells transform into cancerous ones, and they block the pathways that would normally trigger cell death.

In breast cancer, for instance, rising levels of Hsp27 and Hsp70 during malignant transformation help cancer cells dodge two of the body’s main tumor-suppression mechanisms: programmed cell death and the built-in limit on how many times a cell can divide.¹ Another member of the family, Hsp90, goes further by supporting the uncontrolled growth that defines cancer. Together, elevated heat shock proteins don’t just help cancer cells survive heat; they also make tumors more resistant to chemotherapy.²

This doesn’t mean that getting warm triggers cancer. These proteins rise in response to many stresses, and their role in cancer progression is primarily about what happens inside tumors that already exist, not about whether external warmth creates tumors in the first place. The concern is more specific: when cancer cells experience a moderate heat stress that doesn’t kill them outright, the survivors can become harder to eliminate.

The Danger of Incomplete Thermal Ablation

The scenario where heat most clearly promotes cancer spread involves a medical procedure called thermal ablation. Doctors use radiofrequency energy or other heat sources to cook tumors from the inside, destroying them at temperatures above 60°C. When the procedure works as planned and the entire tumor is destroyed, it’s an effective treatment. The trouble comes when the heat doesn’t reach every corner of the tumor.

A heat-ablated tumor has roughly three zones. The center, where temperatures climb well above 60°C, undergoes immediate tissue death. The outermost ring remains largely unaffected. Between them lies a transitional zone where temperatures hover in a sublethal range, roughly 43–50°C, hot enough to injure cells but not hot enough to kill them.³ Surviving tumor cells in that transitional zone don’t just recover. They can become more aggressive.

Research in animal models has shown that incomplete thermal ablation triggers a cascade of pro-growth signals. At the ablation site, surviving tumor cells ramp up proliferation, grow new blood vessels, and produce inflammatory molecules that create a welcoming environment for continued cancer growth. More alarming, these effects aren’t limited to the treated tumor. Distant, untreated tumors in the same animal also show accelerated growth, increased blood vessel formation, and heightened immune cell infiltration of the kind that supports tumor progression rather than fighting it.⁴ The mechanism involves signaling molecules like IL-6, HGF, and VEGF, which surviving cells release in response to the heat injury, essentially broadcasting a growth signal that reaches tumors throughout the body.⁵

This is a recognized clinical challenge, not a theoretical worry. Oncologists designing ablation procedures work to ensure complete coverage of the tumor with lethal temperatures specifically because incomplete treatment carries real risk. The problem isn’t that heat itself spreads cancer. The problem is that a half-measure, heat that wounds a tumor without finishing the job, can make things worse than doing nothing at all.

Heat Pushes Tumor Cells Into the Bloodstream

One of the more unsettling findings from ablation research is that the procedure can physically dislodge cancer cells into the circulation. Using a technique that counts tumor cells flowing through blood vessels in real time, researchers found that circulating tumor cells increased roughly twelve-fold during radiofrequency ablation in a mouse model of liver cancer. The spike began as soon as ablation started, with most of the increase happening within the first few minutes. About three-quarters of these released cells were still alive.⁶ Similar real-time monitoring in a prostate cancer model confirmed this pattern: circulating tumor cells dramatically increase during the ablation procedure.⁷

Part of what allows this to happen is that heat changes the blood vessels around tumors. Hyperthermia causes a rapid increase in the permeability of blood vessel walls by disrupting the adhesion molecules that hold endothelial cells together. Lab studies show that heating causes a significant, reversible opening of gaps between the cells lining blood vessels, making it easier for molecules and cells to pass through.⁸ In tumors, mild hyperthermia increased the rate of molecular exchange across vessel walls by about 200% and allowed transport of particles far larger than what normally passes through.⁹

There’s an interesting irony here. That same vascular permeability increase is exactly what makes heat useful as a drug-delivery tool in cancer therapy, because leakier vessels let chemotherapy drugs penetrate deeper into tumors. The same physical property that could help tumor cells escape also helps anti-cancer drugs get in. Which effect dominates depends on whether the heat is being applied in a controlled therapeutic context or happening in an incomplete, poorly targeted way.

How Surviving Cells Become More Resilient

Beyond the immediate mechanical effects of dislodging cells and opening blood vessels, sublethal heat stress triggers molecular changes that make surviving cancer cells genuinely harder to kill. One key pathway involves a protein called HIF-1α, which cells normally activate under low-oxygen conditions. Heat stress can switch on this same pathway even without oxygen deprivation. In lung cancer cells exposed to thermal treatment, the surviving subpopulation showed increased HIF-1α levels and enhanced viability compared to the original cells.¹⁰

The interaction between heat shock proteins and HIF-1α creates a particularly stubborn survival circuit. After insufficient radiofrequency ablation of lung tumors, high levels of Hsp70 stabilize HIF-1α, which in turn blocks a form of cell death called ferroptosis. This chain of events contributes directly to cancer recurrence after incomplete treatment.¹¹ Meanwhile, the combination of heat shock proteins and HIF-1α works alongside immune-suppressive cells in the tumor environment, including myeloid-derived suppressor cells and cancer-associated fibroblasts, to collectively drive recurrence of liver cancer after thermal ablation.¹²

Cancer cells also communicate these stress signals to distant sites through tiny membrane-bound packages called exosomes. Colon cancer cells release exosomes carrying Hsp90B1, which travel to the liver and reprogram immune cells there, converting them from a tumor-fighting state into a tumor-supporting one. This essentially prepares distant organs to welcome metastatic cells before they even arrive. High levels of Hsp90B1 in patient-derived exosomes were associated with more advanced disease and worse outcomes.¹³

When Heat Fights Cancer Instead

The picture above paints heat as a villain, but that tells only half the story. When heat is applied at the right temperature, for the right duration, and to the right extent, it can trigger a powerful anti-tumor immune response. In rat glioma experiments, heating a tumor on one side of the body to roughly 42–45°C for thirty minutes didn’t just eliminate the heated tumor. The unheated tumor on the opposite flank also disappeared completely. This was accompanied by a flood of immune cells, including natural killer cells and both types of T cells, into both the treated and untreated tumors.¹⁴

The contrast with incomplete ablation is striking. When heat kills the tumor thoroughly at controlled therapeutic temperatures, dying cancer cells release their contents in a way that alerts the immune system, essentially vaccinating the body against the cancer. When heat only wounds the tumor, the surviving cells suppress immunity instead. The difference between these two outcomes often comes down to a few degrees and whether the heat coverage is complete.

Clinically, controlled hyperthermia combined with chemotherapy has shown real benefits. A large randomized trial in patients with high-risk soft tissue sarcoma compared chemotherapy alone to chemotherapy plus regional hyperthermia. After long-term follow-up, the group receiving heat alongside chemo had a lower rate of disease relapse: about 62% experienced relapse compared to 71% in the chemotherapy-only group.¹⁵ Whole-body hyperthermia, where the patient’s core temperature is gently raised to around 40.4°C, has also been used, with target temperature successfully reached in about 90% of treatment sessions in a large clinical analysis.¹⁶

There is a historical caveat worth noting. Early animal research on whole-body hyperthermia found that raising the entire body temperature actually advanced the appearance of metastases, while locally heating just the tumor delayed metastasis.¹⁷ This may explain why modern clinical practice strongly favors local and regional heating over whole-body approaches, and why careful temperature control and imaging guidance are considered essential to safe treatment.

Saunas, Hot Weather, and Everyday Heat

If you’re a cancer patient wondering whether a hot bath or a sauna session will make your disease worse, the epidemiological evidence is reassuring. A large Finnish study following over two thousand men for years found no association between frequent sauna use and cancer risk. Men who used saunas four or more times per week had essentially the same cancer rates as men who went once a week or less. This held true across prostate, gastrointestinal, and lung cancers.¹⁸

The reason everyday environmental heat differs so dramatically from medical hyperthermia is straightforward: a sauna raises your skin temperature and modestly increases your core temperature, but it doesn’t heat a deep-seated tumor to 43°C or above. The thermal ablation risks described earlier require direct, sustained, targeted heating to temperatures far beyond what any natural environmental exposure can produce. Your body’s thermoregulation keeps internal organ temperatures within a narrow range even when you’re sweating in a sauna or walking through a heat wave. The temperatures at which heat shock proteins spike, blood vessel permeability surges, and tumor cells get dislodged are achievable only with medical equipment placed directly at or near the tumor.

What Cold Stress Does to Tumors in Lab Animals

An unexpected twist in this story comes from research on housing temperature in laboratory mice. Standard lab temperatures of around 22°C are comfortable for researchers but chronically cold for mice, whose thermoneutral zone is closer to 30°C. It turns out this constant mild cold stress significantly affects cancer studies. Mice housed at standard cool temperatures show faster tumor growth and suppressed anti-tumor immune responses compared to mice kept at their preferred warmer temperature. Administering a drug that blocks the stress hormone pathway reversed the immune suppression, suggesting that chronic cold stress was driving the effect through the sympathetic nervous system.¹⁹

This finding has profound implications for how we interpret decades of cancer research done in cold-stressed mice. It also offers an unexpectedly positive spin on warmth: being at a comfortable temperature, rather than being chronically chilled, may actually support better immune function against tumors. The lesson is that thermal comfort and extreme heat exposure are very different things, and conflating them leads to confusion about what “heat” does to cancer.

Why the Temperature Window Matters So Much

The recurring theme across all this research is that the biological effects of heat on cancer depend on where you are on the temperature spectrum and how completely the heat reaches the tumor. At one end, comfortable environmental warmth supports normal immune function and poses no demonstrated cancer risk. In the mild fever range of 39–41°C, carefully applied heat can boost immune cell trafficking into tumors and enhance the effectiveness of chemotherapy and radiation. At 42–45°C applied locally and thoroughly, heat can trigger dramatic anti-tumor immune responses that eliminate even distant untreated tumors. But in the sublethal zone of 43–50°C applied incompletely, heat injures tumors just enough to provoke aggressive regrowth, immune evasion, and systemic spread. Above 60°C with complete coverage, thermal ablation destroys tumors outright.

For patients, the practical takeaway is that heat-based cancer therapies are not inherently dangerous, but they require precise execution. The risks emerge specifically when treatment is incomplete, and modern imaging and temperature-monitoring technologies exist precisely to minimize that risk. If you’re undergoing thermal ablation or hyperthermia treatment, the sophistication of the planning and monitoring matters enormously. And if you’re simply living in a warm climate, using a sauna, or running a fever, the temperatures involved are nowhere near the range where these tumor-promoting effects occur. The heat that can help or harm cancer is the focused, sustained, targeted kind that only medical equipment can deliver.